Phospho alpha-Synuclein (S129) Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data

Detection of Phospho-Synuclein-alpha (S129) by Western Blot Western Blot of rat cortex lysate showing specific labeling of the ~15 kDa Synuclein-alpha protein phosphorylated at S129. Immunolabeling is blocked by the phosphopeptide (peptide) used as antigen but not by the corresponding dephosphopeptide (not shown).
Preparation and Storage
Background: alpha-Synuclein
Synuclein-alpha is a 14 kDa member of the synuclein family. It is found in both the neuron nucleus and the cytosol of presynaptic nerve terminals in the brain. Synuclein-alpha is 140 amino acids in length and runs anomalously at 19 kDa in SDS-page. It contains three domains; an N-terminal lipid-binding domain, a central amyloid-binding region, and a C-terminal acidic tail. The N-terminal area (aa 1 - 100) is involved with lipid (membrane) and protein binding. The C-terminus may be regulatory. There is a NAC (non-Ab component of AD amyloid) segment between aa 61 - 95. This has been thought to mediate synuclein-alpha filament formation and microtubial stabilization. Whether it exists as a stand-alone normal cleavage product of synuclein-alpha is unclear. Synuclein-alpha is phosphorylated on multiple sites. S129 undergoes constitutive phosphorylation and dephosphorylation. When phosphorylated, filament formation (and perhaps oligomerization) is promoted. Uncontrolled filament/fibril formation is suggested to be involved in Parkinson’s disease Lewy body formation. Tyrosine phosphorylation also occurs at Y125. Synuclein-alpha is known to bind to, and inhibit, PLD-1 and -2. When phosphorylated at Y125, synuclein-alpha activity is decreased and PLD activity is increased.
- da Costa, C.A. (2003) Curr. Mol. Med. 3:17.
- Ueda, K. et al. (1993) Proc. Natl. Acad. Sci. USA 90:11282.
- Okochi, M. et al. (2000) J. Biol. Chem. 275:390.
- Goers, J. et al. (2003) Biochemistry 42:8465.
- Ahn, B-H. et al. (2002) J. Biol. Chem. 277:12334.
Product Datasheets
Citations for Phospho alpha-Synuclein (S129) Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in alpha -Synuclein Mutant Mice
Authors: Yuki Kishimoto, Wandi Zhu, Waki Hosoda, Jyoti M. Sen, Mark P. Mattson
NeuroMolecular Medicine
-
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in alpha -Synuclein Mutant Mice
Authors: Yuki Kishimoto, Wandi Zhu, Waki Hosoda, Jyoti M. Sen, Mark P. Mattson
NeuroMolecular Medicine
Species: Mouse
Sample Types: Whole Tissue
Applications: Immunohistochemistry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Phospho alpha-Synuclein (S129) Antibody
There are currently no reviews for this product. Be the first to review Phospho alpha-Synuclein (S129) Antibody and earn rewards!
Have you used Phospho alpha-Synuclein (S129) Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image